Camurus’ Interim Report Third Quarter 2021
“Solid third quarter with continued progress in our development pipeline, double-digit quarterly sales growth and strong results development” Summary third quarter 2021 July - September · Total revenue amounted to SEK 154 (100) million, an increase of 54% (54% at CER[1]), whereof product sales were SEK 152 (94) million, an increase of 61% (62% at CER) · Quarterly sales growth was 11% (12% at CER) compared to previous quarter · Operating result was SEK -6 (-23) million, an increase of 73% · Cash position at the end of the quarter was SEK 426 (476) million · Buvidal®